Citations

Clear

421 citation(s) found for "Short, C".

Amyotrophic lateral sclerosis–specific quality of life–short form (ALSSQOL‐SF): A brief, reliable, and valid version of the ALSSQOL‐R
Felgoise, Stephanie H. , Feinberg, Richard A. , Stephens, Helen , Clawson, Lora , Elman, Lauren , Goutman, Stephen A. , McCluskey, Leo, Russell, James W. , Tiryaki, Ezgi , Weiss, Michael D. , Simmons, Zachary , Boylan, Kevin, Goutman, Stephen A , Simmons, Zachary , Barkhaus, Paul E. , Boylan, Khrista , Caress, James B.

Mayo Clinic

Muscle & Nerve | July 20, 2018 | Volume: 58 | Issue: 5 | Pages: 646-654

10.1002/mus.26203 | PMID 30028537 Get It

ABSTRACT Introduction: The Amyotrophic Lateral Sclerosis (ALS)‐Specific Quality of Life instrument and its revised version (ALSSQOL and ALSSQOL‐R) have strong psychometric properties, and have demonstrated research and clinical utility. In this study we aimed to develop a short form (ALSSQOL‐SF) suitable for limited clinic time and patient stamina. Methods: The ALSSQOL‐SF was created using Item Response Theory and confirmatory factor analysis on 389 patients. A cross‐validation sample of 162 patients assessed convergent, divergent, and construct validity of the ALSSQOL‐SF compared with psychosocial and physical functioning measures. Results: The ALSSQOL‐SF consisted of 20 items. Compared with the ALSSQOL‐R, optimal precision was retained, and completion time was reduced from 15–25 minutes to 2–4 minutes. Psychometric properties for the ALSSQOL‐SF and its subscales were strong. Discussion: The ALSSQOL‐SF is a disease‐specific global QOL instrument that has a short administration time suitable for clinical use, and can provide clinically useful, valid information about persons with ALS. Muscle Nerve 58: 646–654, 2018
Objective but Not Subjective Short Sleep Duration Is Associated With Hypertension in Obstructive Sleep Apnea
Ren, Rong , Covassin, Naima , Yang, Linghui , Zhang, Ye , Zhou, Junying , Tan, Lu, Li, Taomei , Li, Xiao , Wang, Yanyan , Zhang, Jihui , Tang, Xiangdong , Tang, Xiangdong , Li, Yun , Tan, Lu, Wing, Yun Kwok , Li, Weimin , Somers, Virend K.

Mayo Clinic

Hypertension | July 9, 2018 | Volume: 72 | Issue: 3 | Pages: 610-617

10.1161/hypertensionaha.118.11027 | PMID 29987105 Get It

Extremes of sleep duration and obstructive sleep apnea (OSA) are both associated with hypertension. We aimed to explore whether sleep duration modifies the relationship between OSA and prevalent hypertension, using both objective and subjective measures of total sleep duration. A total of 7107 OSA patients and 1118 primary snorers were included in the study. Hypertension was defined based either on direct blood pressure measures or on diagnosis by a physician. Objective sleep duration was derived by polysomnography and subjective sleep duration was self-reported. Logistic regression models were used to estimate the associations between objective/subjective sleep duration and hypertension prevalence in OSA and primary snorers. Compared with primary snorers, OSA combined with objective sleep duration of 5 to 6 hours increased the odds of hypertension by 45% (odds ratio, 1.45; 95% confidence interval, 1.14–1.84), whereas OSA combined with objective sleep duration <5 hours further increased the odds of hypertension by 80% (odds ratio, 1.80; 95% confidence interval, 1.33–2.42). These results were independent of major confounding factors frequently associated with OSA or hypertension. In stratified analysis by sleep duration, risk of hypertension in those with extremely short sleep (<5 hours) was not significantly different between OSA and primary snorers, whereas odds were significant for OSA in the other 4 sleep duration strata (5–6, 6–7, 7–8, and >8 hours). No significance was evident using subjective sleep duration. We conclude that objective short sleep duration is associated with hypertension in OSA patients. Extremely short sleep duration in itself may actually be even more detrimental than OSA in terms of hypertension risk.
Arthroscopy and arthrotomy to address intra-articular pathology during PAO for hip dysplasia demonstrates similar short-term outcomes
Bartels, D , Trousdale, Robert T. , Wyles, Cody C. , Bartels, Douglas W., Larson, Dirk R. , Hevesi, Mario , Sierra, Rafael J.

Mayo Clinic

Journal of Hip Preservation Surgery | June 19, 2018 | Volume: 5 | Issue: 3 | Pages: 282-295

10.1093/jhps/hny022 | PMID 30393556 Get It

Short-Term Outcomes in Treatment of Knee Osteoarthritis With 4 Bone Marrow Concentrate Injections
Shaw, Brent , Darrow, Marc, Derian, Armen

Mayo Clinic

Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders | June 18, 2018 | Volume: 11 | Issue: No issue available | Pages: No page available

10.1177/1179544118781080 | PMID 29977117 Get It

Background: Preliminary research suggests that bone marrow concentrate (BMC), which contains mesenchymal stem cells and platelets, is a promising treatment for knee osteoarthritis. The aim of this study was to build on this preliminary research by reporting the short-term progress of 15 patients (20 knees) with knee osteoarthritis through 4 BMC treatments. Methods: Patients underwent four sequential BMC treatments with mean injection times of 13.80 days after the first treatment, 21.40 days after the second treatment, and 33.50 days after the third treatment. The last follow-up was conducted a mean 86 days after the first treatment. Baseline and posttreatment outcomes of resting pain, active pain, lower functionality scale, and overall improvement percentage were compared after each treatment. Results: Patients experienced statistically significant improvements in active pain and functionality score after the first treatment. Additionally, patients experienced a mean decrease in resting pain after the first treatment, yet outcomes were not statistically significant until after the second treatment. On average, patients experienced an 84.31% decrease in resting pain, a 61.95% decrease in active pain, and a 55.68% increase in functionality score at the final follow-up. Patients also reported a mean 67% total overall improvement at study conclusion. Outcomes at the final follow-up after the fourth treatment were statistically significant compared to outcomes at baseline, after first treatment, after second treatment, and after third treatment. Conclusions: These results are promising, and additional research with a larger sample size and longer follow-up is needed to further examine the treatment effectiveness of multiple BMC injections for knee osteoarthritis.
Short-Wave Diathermy
Krusen, Frank H.

Mayo Clinic

Military Medicine | May 7, 2018 | Volume: 87 | Issue: 2 | Pages: 158-163

10.1093/milmed/87.2.158 Get It

The Impact of Age at Time of Ileal Pouch Anal Anastomosis on Short and Long-Term Outcomes in Adults
McKenna, Nicholas P. , Mathis, Kellie L. , Pembérton, John H., Lightner, Amy L. , McKenna, Nicholas P

Mayo Clinic

Inflammatory Bowel Diseases | April 26, 2018 | Volume: 24 | Issue: 8 | Pages: 1857-1865

10.1093/ibd/izy087 | PMID 29718243 Get It

Improved Multiscale Entropy Technique with Nearest-Neighbor Moving-Average Kernel for Nonlinear and Nonstationary Short-Time Biomedical Signal Analysis
Mulpuru, Siva K. , Friedman, Paul A. , Tolkacheva, Elena G. , Arunachalam, S P , Tolkacheva, E G , Arunachalam, Shivaram P. , Kapa, Suraj

Mayo Clinic

Journal of Healthcare Engineering | March 5, 2018 | Volume: 2018 | Issue: No issue available | Pages: 1-13

10.1155/2018/8632436 | PMID 29707188 Get It

Analysis of biomedical signals can yield invaluable information for prognosis, diagnosis, therapy evaluation, risk assessment, and disease prevention which is often recorded as short time series data that challenges existing complexity classification algorithms such as Shannon entropy (SE) and other techniques. The purpose of this study was to improve previously developed multiscale entropy (MSE) technique by incorporating nearest-neighbor moving-average kernel, which can be used for analysis of nonlinear and non-stationary short time series physiological data. The approach was tested for robustness with respect to noise analysis using simulated sinusoidal and ECG waveforms. Feasibility of MSE to discriminate between normal sinus rhythm (NSR) and atrial fibrillation (AF) was tested on a single-lead ECG. In addition, the MSE algorithm was applied to identify pivot points of rotors that were induced in ex vivo isolated rabbit hearts. The improved MSE technique robustly estimated the complexity of the signal compared to that of SE with various noises, discriminated NSR and AF on single-lead ECG, and precisely identified the pivot points of ex vivo rotors by providing better contrast between the rotor core and the peripheral region. The improved MSE technique can provide efficient complexity analysis of variety of nonlinear and nonstationary short-time biomedical signals.
Short delay in initiation of radiotherapy for patients with glioblastoma-effect of concurrent chemotherapy: a secondary analysis from the NRG Oncology/Radiation Therapy Oncology Group database
Blumenthal, Deborah T. , Won, Minhee , Brown, Paul D. , Bokstein, Felix , Brachman, David, Werner‐Wasik, Maria, Hunter, G.K., Valeinis, Egils , Hopkins, Kirsten, Souhami, Luís, Howard, Steven , Lieberman, Frank S. , Shrieve, Dennis C. , Wendland, Merideth M, Robinson, Clifford G. , Corn, Benjamin W. , Robinson, Clifford , Mehta, Minesh P. , Gilbert, Mark R. , Zhang, Peixin

Mayo Clinic

Neuro-Oncology | February 13, 2018 | Volume: 20 | Issue: 7 | Pages: 966-974

10.1093/neuonc/noy017 | PMID 29462493 Get It

Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade
Samson, Adel , Scott, Karen J. , Taggart, David J. , Wilson, Erica , Nuovo, Gerard J. , Thomson, Simon , Mathew, Ryan , Fuller, Martin, Kottke, Timothy, Thompson, Jill , Ilett, Elizabeth J. , Cockle, Julia , Hille, Philip van, Sivakumar, Gnanamurthy, Polson, Euan S. , Turnbull, Samantha , Appleton, Elizabeth , Migneco, G , Rose, Ailsa , Coffey, Matthew, Beirne, Deborah , Collinson, Fiona , Ralph, Christy , Anthoney, Alan , Twelves, Christopher , Furness, Andrew J.S. , Quezada, Sergio A. , Wurdak, Heiko , Errington‐Mais, Fiona , Pandha, Hardev , Harrington, Kevin J. , Selby, Peter J. , Vile, Richard G. , Griffin, Stephen , Stead, Lucy F. , Short, Susan , Melcher, Alan , Taggart, David , Wilson, Erica , Nuovo, Gerard J , Thomson, Simon , Mathew, Ryan K , Kottke, Timothy J, Thompson, Jill M, Ilett, Elizabeth J , Cockle, Julia V , Turnbull, Samantha J , Rose, Ailsa S , Beirne, Deborah A , Ralph, Christy , Alan Anthoney, D , Quezada, Sergio A , Wurdak, Heiko , Errington-Mais, Fiona , Selby, Peter J , Griffin, Stephen , Stead, Lucy F , Short, Susan C , Melcher, Alan A , Harrington, Kevin , West, Emma J. , Corns, Robert A. , Appleton, Elizabeth

Mayo Clinic

Science Translational Medicine | January 3, 2018 | Volume: 10 | Issue: 422 | Pages: No page available

10.1126/scitranslmed.aam7577 | PMID 29298869 Get It

Intravenous infusion of oncolytic reovirus in patients leads to infection of brain tumors, infiltration by cytotoxic T cells, and up-regulation of PD-L1.